Platelets and platelet adhesion molecules: novel mechanisms of thrombosis and anti-thrombotic therapies

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1477-9560
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Platelets and platelet adhesion molecules: novel mechanisms of thrombosis and anti-thrombotic therapies ; volume:14 ; number:1 ; day:4 ; month:10 ; year:2016 ; pages:37-46 ; date:10.2016
Thrombosis journal ; 14, Heft 1 (4.10.2016), 37-46, 10.2016

Creator
Xu, Xiaohong Ruby
Contributor
Carrim, Naadiya
Neves, Miguel Antonio Dias
McKeown, Thomas
Stratton, Tyler W.
Coelho, Rodrigo Matos Pinto
Lei, Xi
Chen, Pingguo
Xu, Jianhua
Dai, Xiangrong
Li, Benjamin Xiaoyi
Ni, Heyu
SpringerLink (Online service)

DOI
10.1186/s12959-016-0100-6
URN
urn:nbn:de:1111-201610303652
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:56 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Xu, Xiaohong Ruby
  • Carrim, Naadiya
  • Neves, Miguel Antonio Dias
  • McKeown, Thomas
  • Stratton, Tyler W.
  • Coelho, Rodrigo Matos Pinto
  • Lei, Xi
  • Chen, Pingguo
  • Xu, Jianhua
  • Dai, Xiangrong
  • Li, Benjamin Xiaoyi
  • Ni, Heyu
  • SpringerLink (Online service)

Other Objects (12)

Anti-thrombotic effects of arteanoflavone by regulating cyclic nucleotides and aggregation on human platelets

Anti-thrombotic effects of arteanoflavone by regulating cyclic nucleotides and aggregation on human platelets

Platelets and thrombosis

Platelets and thrombosis

Anti-thrombotic agents derived from snake venom proteins

Anti-thrombotic agents derived from snake venom proteins

Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis

Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis

Correction to: Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis

Correction to: Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis

Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI

Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI

Novel oral anticoagulants: A new era in anti-thrombotic therapy

Novel oral anticoagulants: A new era in anti-thrombotic therapy

Anti-thrombotic effect of a factor Xa inhibitor TAK-442 in a rabbit model of arteriovenous shunt thrombosis stimulated with tissue factor

Anti-thrombotic effect of a factor Xa inhibitor TAK-442 in a rabbit model of arteriovenous shunt thrombosis stimulated with tissue factor

Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?

Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?

NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia

NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia

Anti-thrombotic effects of α-linolenic acid isolated from Zanthoxylum bungeanum Maxim seeds

Anti-thrombotic effects of α-linolenic acid isolated from Zanthoxylum bungeanum Maxim seeds

Antithrombotic therapy with rivaroxaban in five patients with paroxysmal nocturnal haemoglobinuria and thrombotic events

Antithrombotic therapy with rivaroxaban in five patients with paroxysmal nocturnal haemoglobinuria and thrombotic events

Related objects